Cue Biopharma (CUE) announced that Lucinda Warren, who has served as Cue Biopharma’s chief financial and business officer since February and previously as Cue Biopharma’s chief business officer from September 2024 until February, has been appointed interim president and CEO. Usman Azam has stepped down as president and CEO and as a director, effective March 26.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUE: